Fludarabine phosphate (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Fludarabine phosphate drug offered from Actavis Pharma, Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Fludarabine phosphate |
| SUBSTANCE NAME: | FLUDARABINE PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-03-02 |
| END MARKETING DATE: | 0000-00-00 |
Fludarabine phosphate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Fludarabine phosphate from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/mL) |
| START MARKETING DATE: | 2017-03-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 45963-621_c13b73e1-fb00-48cd-b858-f4b9896deca0 |
| PRODUCT NDC: | 45963-621 |
| APPLICATION NUMBER: | ANDA203738 |
Other FLUDARABINE PHOSPHATE Pharmaceutical Manufacturers / Labelers:
